Competing For Share Of Global Pharmaceutical Industry Spend In 2010-2011: Supplier Marketing & Sales Strategies & Industry Outlook


#75313

120pages

ICD Research

$ 2000

In Stock


Competing For Share Of Global Pharmaceutical Industry Spend In 2010-2011 is a new report published by ICD Research that analyzes how industry suppliers media spend, marketing and sales strategies & practices and business planning will be shaped in 2010 to 2011. In an uncertain economic climate this report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading technology suppliers. The report also identifies drug manufacturers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels.

Scope

  • Opinions and forward looking statements of over 320 industry executives are captured in our in-depth survey, of which 49% represent Directors, C-levels & Departmental Heads 
  • Analysis on media channel spend, marketing and sales practices and industry developments by drugs manufacturing companies and their suppliers
  • Key topics include suppliers media spend activity, marketing and sales behaviors & strategies, threats & opportunities for the industry and how these have been affected by the economic uncertainty
  • In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats
  • The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations
  • The geographical scope of the research is global drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East
Reasons To Buy

  • Benchmark your sales and marketing plans with industry competitors to effectively determine strategy
  • Identify the specific marketing approaches your competitors are using to win business during the recessionary climate
  • Better promote your business by aligning your capabilities and business practices with your customers changing needs during these times of market uncertainty
  • Predict how the industry will grow, consolidate and where it will stagnate
  • Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry
Key Highlights

  • The majority of pharmaceutical industry respondents identified the US, Canada and Singapore, Taiwan and Hong Kong to be the fastest growing markets in next 12 months among developed nations due to new approaches to customer needs, product affordability, effective distribution and rise of these regions as clinical trial destinations 
  • 63% of industry players are looking to increase their marketing expenditure over the next 12 months, with only 14% looking to decrease it
  • 72% of companies believe that the demonstration of confidence to their customers from increased marketing activity in the current business climate can give their company an edge
Table Of Contents

Chapter 1: Executive Summary

Chapter 2: Introduction
Heading: Profile Of Survey Respondents

Chapter 3: Industry Dynamics
Heading: Revenue Growth Expectations In The Pharmaceutical Industry
Heading: Future Developments In Competitive Structure In The Industry
Heading: Merger And Acquisition Activity Predictions

Chapter 4: Pharmaceutical Market Growth Outlook
Heading: Regional Growth Forecasts In The Pharmaceutical Industry By Country
Heading: Market Growth Forecasts By Industry Sector

Chapter 5: Threats And Opportunities For The Pharmaceutical Industry
Heading: Leading Business Concerns For The Period 2010-2011
Heading: Key Actions To Overcome Business Threats: Cost Management
Heading: Key Actions To Overcome Business Threats: Driving Sales
Heading: Key Supplier Actions To Maintain And Win Buyer Business

Chapter 6: Pharmaceutical Industry Supplier Marketing Spend Activity
Heading: Annual Marketing Budgets: Pharmaceutical Industry Suppliers
Heading: Planned Change In Marketing Expenditure Levels: Pharmaceutical Industry Suppliers
Heading: Future Investment By Media Channel: Pharmaceutical Industry Suppliers
Heading: Supplier's Future Investment In Marketing And Sales Technology

Chapter 7: Marketing And Sales Behaviors And Strategies In 2010-2011
Heading: Key Marketing Aims For 2010: Suppliers To The Industry
Heading: How Suppliers Are Adapting Marketing Activities During The Economic Uncertainty
Heading: Most Rated Uses Of New Media For Prospecting For Business: Suppliers To The Industry
Heading: Critical Success Factors For Choosing A Marketing Agency: Suppliers To The Industry

Chapter 8: Appendix

Table 1: Count Of Global Pharmaceutical Industry Survey Respondents By Company Type (Number Of Respondents), 2010 Industry Survey
Table 2: Buyer Respondents By Organizations Global Turnover (% Buyer Respondents), Global Pharmaceutical Industry, 2010
Table 3: Buyer Respondents By Job Role (% Buyer Respondents), Global Pharmaceutical Industry, 2010
Table 4: Buyer Respondents By Organizations Total Employee Size (% Buyer Respondents), Global Pharmaceutical Industry, 2010
Table 5: Buyer Respondents By Region (% Buyer Respondents), Global Pharmaceutical Industry, 2010
Table 6: Supplier Respondents By Job Role (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 7: Supplier Respondents By Organizations Global Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 8: Supplier Respondents By Organization's Total Employee Size (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 9: Supplier Respondents By Region (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 10: Company Revenue Growth Optimism Trend By Global Pharmaceutical Industry Company Type: Pharmaceutical Manufacturers, CRO / CMO Companies, Pharmaceutical Industry Suppliers, Pharmaceutical Industry Suppliers (% All Respondents), 2009-2010
Table 11: Company Revenue Growth Optimism Trend In The Global Pharmaceutical Industry By Region: North America, Europe, Asia Pacific, Rest Of The World (% All Respondents), 2009-2010
Table 12: Company Revenue Growth Optimism In The Global Pharmaceutical Industry By Turnover (% All Respondents), 2010
Table 13: Pharmaceutical Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Pharmaceutical Manufacturer Respondents), 2010
Table 14: CRO / CMO Company Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% CRO / CMO Company Respondents), 2010
Table 15: Pharmaceutical Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Pharmaceutical Industry Supplier Respondents), 2010
Table 16: Pharmaceutical Manufacturer Predictions Of The Fastest And Slowest Growing Industry Sectors (% Pharmaceutical Manufacturer Respondents), 2010
Table 17: CRO / CMO Company Predictions Of The Fastest And Slowest Growing Industry Sectors (% CRO / CMO Company Respondents), 2010
Table 18: Pharmaceutical Industry Supplier Predictions Of The Fastest And Slowest Growing Industry Sectors (% Pharmaceutical Industry Supplier Respondents), 2010
Table 19: Global Pharmaceutical Industry Predictions Of The Fastest And Slowest Growing Industry Sectors By Region: North America, Europe, Asia Pacific, Rest Of The World (% 'Very Strong Growth' And 'Strong Growth' Combined, All Respondents), 2010
Table 20: Pharmaceutical Manufacturer Vs. CRO / CMO Company Vs. Pharmaceutical Industry Supplier: Leading Business Concerns For The Period 2010-2011 Among Global Pharmaceutical Industry Buyers And Suppliers (% All Respondents), 2010
Table 21: Leading Business Concerns For The Period 2010-2011 Among Global Pharmaceutical Industry Buyers And Suppliers By Region: North America, Europe, Asia Pacific, Rest Of The World (% All Respondents), 2010
Table 22: Leading Business Concerns For The Period 2010-2011 Among Global Pharmaceutical Industry Buyers And Suppliers By Company Turnover (% All Respondents), 2010
Table 23: Most Important Actions Being Implemented To Facilitate Cost Containment In 2010-2011 In The Global Pharmaceutical Industry (% All Respondents), 2010
Table 24: Most Important Actions Being Implemented To Facilitate Cost Containment In 2010-2011 In The Global Pharmaceutical Industry Senior Level Responses Only (% CEO/MD/Board Level Respondents), 2010
Table 25: Most Important Actions Being Implemented For Driving Sales To Overcome Present Business Challenges In 2010-2011 In The Global Pharmaceutical Industry: Buyer Vs. Supplier Comparison (% All Respondents), 2010
Table 26: Most Important Actions Being Implemented For Driving Sales To Overcome Present Business Challenges In 2010-2011 In The Global Pharmaceutical Industry (% All Respondents), 2010
Table 27: Most Important Actions Being Implemented For Driving Sales To Overcome Present Business Challenges In 2010-2011 In The Global Pharmaceutical Industry Senior Level Responses Only (% CEO/MD/Board Level Respondents), 2010
Table 28: Most Important Actions Being Implemented For Driving Sales To Overcome Present Business Challenges In 2010-2011 In The Global Pharmaceutical Industry: Buyer Vs. Supplier Comparison (% All Respondents), 2010
Table 29: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Supplier Responses Vs. All Buyer Responses (% All Respondents), 2010
Table 30: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Pharmaceutical Manufacturer Vs. CRO / CMO Company (% Buyer Respondents), 2010
Table 31: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Analysis Of Buyer Respondents By Company Turnover (% Buyer Respondents), 2010
Table 32: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Analysis Of All Buyer Respondents By Procurement Budget (% Buyer Respondents), 2010
Table 33: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2010
Table 34: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Analysis Of All Buyer Respondents By Purchasing Decision Seniority (% Buyer Respondents With Purchasing Decision Influence), 2010
Table 35: Annual Marketing Budget In US Dollars: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 36: Annual Marketing Budget In US Dollars By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 37: Annual Marketing Budget In US Dollars By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 38: Pharmaceutical Industry Supplier Attitudes And Approaches To Existing Marketing Practices: Level Of Agreement To The Following Statement (% Pharmaceutical Industry Supplier Respondents), 2010
Table 39: Planned Change In Marketing Expenditure Levels Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010 (With Comparison To 2009 Expectations)
Table 40: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010 (With Comparison To 2009 Expectations)
Table 41: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 42: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 43: Expected Increase Or Decrease In Expenditure By Media Channel Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 44: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 45: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 46: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 47: Key Marketing Aims Over The Next Year: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 48: Expected Adaptations To Marketing Activities During Global Economic Uncertainty: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 49: Expected Adaptations To Marketing Activities During Global Economic Uncertainty By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 50: Expected Adaptations To Marketing Activities During Global Economic Uncertainty By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 51: Pharmaceutical Industry Supplier Attitudes And Approaches To Existing Marketing Practices: Level Of Agreement To The Following Statement (% Pharmaceutical Industry Supplier Respondents), 2010
Table 52: Most Rated New Media Channels For New Business Generation: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 53: Most Rated New Media Channels For New Business Generation: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 54: Most Rated New Media Channels For New Business Generation By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 55: Critical Success Factors For Choosing A Marketing Agency: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 56: Critical Success Factors For Choosing A Marketing Agency By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 57: Critical Success Factors For Choosing A Marketing Agency By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 58: Critical Success Factors For Choosing A Marketing Agency By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Table 59: Critical Success Factors For Choosing A Marketing Agency By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 60: Critical Success Factors For Choosing A Marketing Agency By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Table 61: Critical Success Factors For Choosing A Marketing Agency By Marketing Budget (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Table 62: Pharmaceutical Industry Supplier Attitudes And Approaches To Existing Marketing Practices: Level Of Agreement To The Following Statement (% Pharmaceutical Industry Supplier Respondents), 2010
Table 63: Pharmaceutical Industry Supplier Attitudes And Approaches To Existing Marketing Practices: Level Of Agreement To The Following Statement (% Pharmaceutical Industry Supplier Respondents), 2010
Table 64: Survey Results Closed Questions

List Of Figures

Figure 1: Company Revenue Growth Optimism Trend By Global Pharmaceutical Industry Company Type: Pharmaceutical Manufacturers, CRO / CMO Companies, Pharmaceutical Industry Suppliers, Pharmaceutical Manufacturing Industry Suppliers (% All Respondents), 2009-2010
Figure 2: Company Revenue Growth Optimism Trend In The Global Pharmaceutical Industry (% All Respondents), 2009-2010
Figure 3: Company Revenue Growth Optimism Trend In The Global Pharmaceutical Industry By Region: North America, Europe, Asia Pacific, Rest Of The World (% All Respondents), 2009-2010
Figure 4: Company Revenue Growth Optimism Trend In The Pharmaceutical Industry Over The Next 12 Months: Global Pharmaceutical Industry Vs. Other Industries (% All Respondents), 2010
Figure 5: Key Expected Changes In Business Structure In The Global CRO / CMO Company Industry (% CRO / CMO Company Respondents), 2010
Figure 6: Key Expected Changes In Business Structure In The Global Pharmaceutical Companies Industry (% Pharmaceutical Manufacturer Respondents), 2010
Figure 7: Key Expected Changes In Business Structure In The Global Pharmaceutical Industry Supplier Industry (% Pharmaceutical Industry Supplier Respondents), 2010
Figure 8: Merger and Acquisition Activity Expectations Over The Next 12 Months In The Global Pharmaceutical Manufacturer Industry (% Pharmaceutical Manufacturer Industry Respondents), 2009-2010 Trend Forecast
Figure 9: Merger and Acquisition Activity Expectations Over The Next 12 Months In The Global Contract Research Organization (CRO) / Contract Manufacturing Organization (CMO) Industry: (% Contract Research Organization (CRO) / Contract Manufacturing Organization (CMO) Industry Respondents), 2009-2010 Trend Forecast
Figure 10: Merger and Acquisition Activity Expectations Over The Next 12 Months In The Global Pharmaceutical Industry Supplier Industry (% Pharmaceutical Industry Supplier Industry Respondents), 2009-2010 Trend Forecast
Figure 11: Pharmaceutical Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Pharmaceutical Manufacturer Respondents), 2010
Figure 12: CRO / CMO Company Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% CRO / CMO Company Respondents), 2010
Figure 13: Pharmaceutical Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Pharmaceutical Industry Supplier Respondents), 2010
Figure 14: Pharmaceutical Manufacturer Predictions Of The Fastest And Slowest Growing Industry Sectors (% Pharmaceutical Manufacturer Respondents), 2010
Figure 15: CRO / CMO Company Predictions Of The Fastest And Slowest Growing Industry Sectors (% CRO / CMO Company Respondents), 2010
Figure 16: Pharmaceutical Industry Supplier Predictions Of The Fastest And Slowest Growing Industry Sectors (% Pharmaceutical Industry Supplier Respondents), 2010
Figure 17: Global Pharmaceutical Industry Predictions Of The Fastest And Slowest Growing Industry Sectors By Region: North America, Europe, Asia Pacific, Rest Of The World (% 'Very Strong Growth' And 'Strong Growth' Combined, All Respondents), 2010
Figure 18: Leading Business Concerns For The Period 2010-2011 Among Global Pharmaceutical Industry Buyers And Suppliers (% All Respondents), 2010
Figure 19: Pharmaceutical Manufacturer Vs. CRO / CMO Company Vs. Pharmaceutical Industry Supplier: Leading Business Concerns For The Period 2010-2011 Among Global Pharmaceutical Industry Buyers And Suppliers (% All Respondents), 2010
Figure 20: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Supplier Responses Vs. All Buyer Responses (% All Respondents), 2010
Figure 21: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Pharmaceutical Manufacturer Vs. CRO / CMO Company (% Buyer Respondents), 2010
Figure 22: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business In The Global Pharmaceutical Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2010
Figure 23: Annual Marketing Budget In US Dollars: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 24: Annual Marketing Budget In US Dollars: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 25: Annual Marketing Budget In US Dollars: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Figure 26: Annual Marketing Budget In US Dollars By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 27: Annual Marketing Budget In US Dollars By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Figure 28: Annual Marketing Budget In US Dollars By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 29: Annual Marketing Budget In US Dollars By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Figure 30: Planned Change In Marketing Expenditure Levels Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010 (With Comparison To 2009 Expectations)
Figure 31: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010 (With Comparison To 2009 Expectations)
Figure 32: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 33: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 34: Planned Change In Marketing Expenditure Levels Over The Next 12 Months By Revenue Growth Expectations (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 35: Expected Increase Or Decrease In Expenditure By Media Channel Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 36: Expected Increase In Expenditure By Media Channel Over The Next 12 Months By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 37: Expected Increase In Expenditure By Media Channel Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 38: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 39: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 40: Planned Investment In Marketing And Sales Technologies Over The Next 12 Months By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 41: Key Marketing Aims Over The Next Year: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 42: Most Important Key Marketing Aims Over The Next Year By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 43: Most Important Key Marketing Aims Over The Next Year By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 44: Most Important Key Marketing Aims Over The Next Year By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 45: Expected Adaptations To Marketing Activities During Global Economic Uncertainty: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 46: Expected Adaptations To Marketing Activities During Global Economic Uncertainty By Company Turnover (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 47: Expected Adaptations To Marketing Activities During Global Economic Uncertainty By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 48: Most Rated New Media Channels For New Business Generation: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 49: Most Rated New Media Channels For New Business Generation: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 50: Most Rated New Media Channels For New Business Generation By Region: North America, Europe, Asia Pacific, Rest Of The World (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 51: Critical Success Factors For Choosing A Marketing Agency: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 52: Critical Success Factors For Choosing A Marketing Agency: Pharmaceutical Industry Supplier (% Supplier Respondents), Global Pharmaceutical Industry, 2009
Figure 53: Critical Success Factors For Choosing A Marketing Agency By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2010
Figure 54: Critical Success Factors For Choosing A Marketing Agency By Expected Change In Future Marketing Expenditure (% Supplier Respondents), Global Pharmaceutical Industry, 2009